Matches in Nanopublications for { ?s ?p "[The host conditioning with low-dose basiliximab may augment the efficacy of AIT for cancer using activated autologous lymphocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP819879.RAU11Liv0dPE8rxaiae_ZxjY2VcysrJ53b2o9VMjhHjiU130_assertion description "[The host conditioning with low-dose basiliximab may augment the efficacy of AIT for cancer using activated autologous lymphocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP819879.RAU11Liv0dPE8rxaiae_ZxjY2VcysrJ53b2o9VMjhHjiU130_provenance.
- NP977176.RAD_x52xSKG9Z9ZYtTX4NIzl1JM0W7eULcxk7eoix9UOw130_assertion description "[The host conditioning with low-dose basiliximab may augment the efficacy of AIT for cancer using activated autologous lymphocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP977176.RAD_x52xSKG9Z9ZYtTX4NIzl1JM0W7eULcxk7eoix9UOw130_provenance.
- NP977124.RAOu5wb_-Bk0JGJuzAjkzymuHp_wsb3cPZPEN2RjoWsZ0130_assertion description "[The host conditioning with low-dose basiliximab may augment the efficacy of AIT for cancer using activated autologous lymphocytes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP977124.RAOu5wb_-Bk0JGJuzAjkzymuHp_wsb3cPZPEN2RjoWsZ0130_provenance.